10.1016/j.expneurol.2006.10.013 27 CaoY.YangL.QiaoX.XueC.XuJ
Denatonium benzoate (0-25 mM, 24 h) inhibits the proliferation of RBL-2H3 and KU812 cells when above 0.1 mM [2]
The intervention duration was 2 weeks in one trial (Reference Revuelta-Iniesta and Al-Dujaili39) , 4 weeks in three trials (Reference Ahmed Al-Naggar, Osman and Abdulghani23,Reference Lecoultre, Carrel and Egli32,Reference Mortazavi, Paknahad and Hasanzadeh34) , 8 weeks in nine trials (Reference Basu, Betts and Mulugeta26,Reference Cardoso, Salgado and Cesar28,Reference Hochkogler, Schweiger and Rust29,Reference Martnez-Lpez, Sarri and Mateos33Reference Mousavi, Vafa and Neyestani35,Reference Superko, Bortz and Williams40,Reference Vieira Senger, Schwanke and Gomes43,Reference Wedick, Brennan and Sun44) , 12 weeks in four trials (Reference Bak and Grobbee25,Reference Kajimoto, Kajimoto and Yabune30,Reference Kobayashi, Kawano and Ukawa31,Reference Nabi, Sedighinejad and Haghighi37) and longer than 12 weeks in the other five trials (Reference Alperet, Rebello and Khoo24,Reference Bhn, Croft and Burrows27,Reference Ohnaka, Ikeda and Maki38,Reference Toolsee, Aruoma and Gunness41,Reference van Dusseldorp, Katan and van Vliet42)
Obesity, Atherosclerosis and the Vascular Endothelium: Mechanisms of Reduced Nitric Oxide Bioavailability in Obese Humans
51 5 How Is Chronic Kidney Disease Diagnosed and Monitored
